Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
Not CRISPR data: the image illustrates antibody quality for visualizing CRISPR experiment results.
COL6A1 CRISPR/Cas9 KO Plasmid (h): sc-401069
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- COL6A1 CRISPR/Cas9 Knockout (KO) Plasmid (h) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the COL6A1 genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: COL6A1 Antibody (B-4): sc-377143
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
COL6A1 CRISPR/Cas9 KO Plasmid (h) | sc-401069 | 20 µg | $397.00 |
Overview
COL6A1 encodes the collagen type VI alpha 1 chain, a core component of collagen VI microfibrils that assemble within the extracellular matrix and contribute to tissue tensile strength and cell–matrix adhesion. Collagen VI networks coordinate extracellular matrix organization and influence mechanotransduction, survival signaling, and cellular differentiation in connective tissues, with functional links to integrin-mediated pathways and basement membrane stability. Altered COL6A1 expression or matrix incorporation can perturb extracellular matrix remodeling and stromal architecture, affecting myofiber integrity and fibroblast behavior. Dysregulation of collagen VI has been associated with neuromuscular and connective tissue phenotypes and is also studied in the context of fibrosis and tumor-associated matrix remodeling.
COL6A1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the COL6A1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the COL6A1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the COL6A1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish COL6A1 protein expression.
This CRISPR knockout system enables efficient generation of COL6A1-deficient cell models for investigation of COL6A1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting COL6A1 exon(s) critical for COL6A1 function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple COL6A1 genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by COL6A1 CRISPR/Cas9 KO Plasmid (h) and COL6A1 CRISPR/Cas9 KO Plasmid (h2) target distinct sites within the COL6A1 locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by COL6A1 HDR Plasmid (h) and COL6A1 HDR Plasmid (h2) contain a puromycin resistance cassette and an RFP reporter flanked by COL6A1 homology arms to support homology-directed repair at defined COL6A1 target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.